About Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement
Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement is a rare disease catalogued by Orphanet (ORPHA:168947). It is associated with the PDGFRA gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement trials.
Search ClinicalTrials.gov for "Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement" or filter by Orphanet code ORPHA:168947 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement. Updated daily.